Skip to main content
. 2021 Jul 12;13(7):1067. doi: 10.3390/pharmaceutics13071067

Figure 9.

Figure 9

MSNs in the application of anti-cancer PDT. PEG-modified MSNs deliver photosensitizers into tumor cells and trigger their release upon the irradiation of green light, leading to the generation of reactive oxygen and cancer ablation.